PR Newswire Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD) by Money Compass May 4, 2026
PR Newswire NYSE Content Advisory: Pre-Market Update + York Space Systems to Debut on NYSE After IPO by Money Compass January 29, 2026
PR Newswire Building Accessible Over-Ear ANC Experiences: QCY’s Vision Reflected Through H3S by Money Compass January 29, 2026
PR Newswire DORCO Wins 2025 GOOD DESIGN® Award; Global Traction Continues for the Flagship Razor by Money Compass January 29, 2026
PR Newswire Over 80 Global, Nordic, Baltic and Arctic CEOs and Leaders of Industry, Finance, Technology and Science Meet in Stockholm to Launch The Origination Finance Studios by Money Compass January 29, 2026
PR Newswire Over 80 Global, Nordic, Baltic and Arctic CEOs and Leaders of Industry, Finance, Technology and Science Meet in Stockholm to Launch The Origination Finance Studios by Money Compass January 29, 2026
PR Newswire Bedsure Expands Offline Retail Footprint With Launch of Its GentleSoft® Ribbed Plush Blanket In Targets Nationwide by Money Compass January 29, 2026
PR Newswire XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision by Money Compass January 29, 2026
